Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Central Eastern Europe and Russia. Lung-EPICLIN

NCT01069835 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01069835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Central Eastern Europe and Russia. Lung-EPICLIN
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
March 31, 2012
Enrollment
840 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer